ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.49
0.00%
US Tech 100
19,514.00
0.54%
S&P 500
5,487.03
0.25%
US Dollar vs CAD
1.37105
0.03%
Bitcoin
66,142.39
1.81%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Abbott Laboratories (ABT)

  7. Abbott Laboratories (ABT) News

ABT

Abbott Laboratories (ABT)

Abbott Laboratories
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ABT
DateTimeSourceHeadlineSymbolCompany
06/14/202411:01AMPR Newswire (US)Abbott Declares 402nd Consecutive Quarterly DividendNYSE:ABTAbbott Laboratories
06/10/20247:00AMPR Newswire (US)Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring SystemsNYSE:ABTAbbott Laboratories
06/03/20248:00AMPR Newswire (US)Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD PatientsNYSE:ABTAbbott Laboratories
05/30/20243:07PMEdgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:ABTAbbott Laboratories
05/14/20244:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
05/10/20243:52PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
05/08/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
05/07/20245:59PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
04/29/20248:00AMPR Newswire (US)Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the KneeNYSE:ABTAbbott Laboratories
04/17/202410:37AMIH Market NewsAbbott Laboratories Reports Strong Q1 Sales Growth Amid Earnings Decline, Raises Full-Year GuidanceNYSE:ABTAbbott Laboratories
04/17/20246:30AMPR Newswire (US)Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance RangesNYSE:ABTAbbott Laboratories
04/17/20245:59AMIH Market NewsUS Index Futures See Gains, Oil Prices DipNYSE:ABTAbbott Laboratories
04/03/20246:12AMIH Market NewsCal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and MoreNYSE:ABTAbbott Laboratories
04/02/20248:00AMPR Newswire (US)Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart ValveNYSE:ABTAbbott Laboratories
04/01/20248:00AMPR Newswire (US)Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's BedsideNYSE:ABTAbbott Laboratories
03/27/20243:30PMPR Newswire (US)Abbott Hosts Conference Call for First-Quarter EarningsNYSE:ABTAbbott Laboratories
03/19/20247:00AMPR Newswire (Canada)Une première au Canada -- Abbott fait progresser le traitement de la douleur chronique grâce au plus petit système de stimulation de la moelle épinière implantée et rechargeable au mondeNYSE:ABTAbbott Laboratories
03/19/20247:00AMPR Newswire (Canada)Canadian First - Abbott Advances Chronic Pain Management with the World's Smallest Implanted, Rechargeable Spinal Cord Stimulation SystemNYSE:ABTAbbott Laboratories
03/06/20248:00AMPR Newswire (US)Real-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 DiabetesNYSE:ABTAbbott Laboratories
03/04/20246:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20246:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20246:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20246:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20246:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20246:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20245:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20245:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20245:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20245:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/01/20244:53PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
 Showing the most relevant articles for your search:NYSE:ABT

Your Recent History

BIT
UC466R
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved